Skip to main content
logo
Paradigm Biopharmaceuticals Limited (ASX:PAR)
Australia flag Australia · Delayed Price · Currency is AUD
0.2600
-0.0250 (-8.77%)
Sep 11, 2026, 12:02 PM AEST

ASX:PAR Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
-----0.08
Revenue Growth
-----285.52%
Gross Profit
-0.01-0.01-0.02-0.01-0.02-0.06
Operating Income
-61.19-61.19-23.34-65.11-60.09-47.93
Net Income
-56.33-56.33-18.77-58.73-51.91-39.25
Earnings Per Share
-0.15-0.15-0.06-0.20-0.21-0.17
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
15.4415.4416.8217.8756.3839.72
Total Debt
7.517.510.010.240.340.62
Net Cash (Debt)
7.937.9316.8117.6356.0439.1
Net Cash Growth
48.13%-52.80%-4.62%-68.54%43.30%-44.40%
Net Cash Per Share
0.020.020.050.060.220.17

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-43.69-43.69-15.99-65.94-45.19-32.21
Capital Expenditures
------
Free Cash Flow
-43.69-43.69-15.99-65.94-45.19-32.21
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
------81.45%
Operating Margin
------60498.78%
Pretax Margin
------49542.54%
Profit Margin
------49542.54%
FCF Margin
------40650.90%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Forward PE
-14.0514.0514.05--
PS Ratio
-----2829.64